Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
Jumatano, 15 Julai 2026, 2:43:25 GMT +3
Adrenal Hormones and Synthetic Substitutes
Adrenal Hormones and Synthetic Substitutes
Adrenal Hormones and Synthetic Substitutes
Name of drug | Dosage forms and Strengths | Level of medicine |
Betamethasone | Injection 4mg/mL | D |
Dexamethasone | Tablet 0.5mg; 4mg | D |
Injection (as sodium phosphate) 10mg/mL | B | |
Hydrocortisone | Powder for Solution for Injection/Infusion 100 mg (as sodium succinate) | A |
Methylprednisolone | 1000 mg powder and solvent for solution for injection/infusion; Tablet 4mg; 8mg; | D |
Metyrapone | Tablet 250mg | S |
Prednisolone | Tablet 5mg | A |
Triamcinolone | Injection 40mg/mL; Cream 0.1% | S |
Oestrogens
Name of drug | Dosage forms and Strengths | Level of medicine |
Ethinyloestradiol | Tablet 50mcg | A |
Ovulation Inducers
Name of drug | Dosage forms and Strengths | Level of medicine |
Clomiphene | Tablet 50mg | C |
Progesterone
Name of drug | Dosage forms and Strengths | Level of medicine |
Dydrogestrone | 10mg tablet | S |
Etonorgestrel | Implant 68mg | A |
Levonorgestrel | Tablet 0.03mg, 0.07mg, 0.75mg | A |
Implant 75mg | A | |
Medroxyprogesterone | Injection acetate (depot) 150mg | A |
Norethisterone | Tablet 5mg | C |
Androgens
Name of drug | Dosage forms and Strengths | Level of medicine |
Testosterone | Injection, 30 mg/1.5mL;100mg/mL; 200mg/mL; Cream | S |
Contraceptives
Name of drug | Dosage forms and Strengths | Level of medicine |
Ethinyloestradiol + Norgestrel | Tablet 0.03mg + 0.3mg | A |
Ethinylestradiol Levonorgestrel | Tablet 0.03mg + 0.15mg | A |
Ethinylestradiol Desogestrel | Tablet 0.03mg + 0.15mg | A |
Imeandikwa:
Alhamisi, 4 Juni 2026, 9:40:08 GMT +3
References:

